Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HP-501 SR by Hinova Pharmaceuticals for Gouty Arthritis (Gout): Likelihood of Approval
HP-501 SR is under clinical development by Hinova Pharmaceuticals and currently in Phase II for Gouty Arthritis (Gout). According to...
Data Insights
HP-501 SR by Hinova Pharmaceuticals for Hyperuricemia: Likelihood of Approval
HP-501 SR is under clinical development by Hinova Pharmaceuticals and currently in Phase II for Hyperuricemia. According to GlobalData, Phase...